Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ
Closed
Aug 21, 2026
Day's Range
10.1452 wk Range
9.86Overview - DMII - Drugs Made In America Acquisition II Corp.
Key Statistics
Valuation
Enterprise Value
645.38M
P/E (Trailing)
‪34.96‬
PEG Ratio
‪-0.0045‬
Price / Book
‪1.31‬
EV / EBITDA
‪-348.05‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪0.82%‬
Return on Equity
‪0.85%‬
Ownership
Shares Outstanding
63.70M
Float
50.25M
Short % of Shares Outstanding
‪0.22%‬
Held by Insiders
‪15.21%‬
Held by Institutions
‪72.44%‬
Price stats
50-Day Avg
‪10.10‬
200-Day Avg
‪10.01‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - DMII - Drugs Made In America Acquisition II Corp.
Peers - DMII - Drugs Made In America Acquisition II Corp.
Peer Comparison
Compared with companies in Shell Companies listed on NASDAQ.
- DMDMIINASDAQDrugs Made In America Acquisition II Corp.645.91MMarket Cap+2.56%52-week change34.97P/E (Trailing)‪0.00%‬Profit Margin
- SLVRNASDAQSprott Silver Miners & Physical Silver ETF1.58BMarket Cap+47.33%52-week change26.71P/E (Trailing)—Profit Margin
- AVRNASDAQAnteris Technologies Ltd.874.13MMarket Cap+58.80%52-week change-3.52P/E (Trailing)‪70.25%‬Profit Margin
- CCXINASDAQChemoCentryx Inc811.54MMarket Cap+29.58%52-week change-7.72P/E (Trailing)‪99.05%‬Profit Margin
- CECEPFNASDAQCantor Equity Partners IV, Inc.590.93MMarket Cap+2.03%52-week change27.95P/E (Trailing)‪0.00%‬Profit Margin
- DBCANASDAQD. Boral Acquisition I Corp.555.37MMarket Cap+1.40%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- MEMEVONASDAQM Evo Global Acquisition Corp II499.00MMarket Cap+1.20%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - DMII - Drugs Made In America Acquisition II Corp.
About
Drugs Made In America Acquisition II Corp. is a special purpose acquisition company (SPAC) established in 2024 with the primary objective of effecting business combinations through mergers, share exchanges, asset acquisitions, or similar transactions. The company targets the pharmaceutical industry, aiming to identify…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
